FDA Orphan Drugs

  • Share karmadata on Twitter
  • Share karmadata on Facebook
  • Share karmadata on Pinterest
  • Share karmadata on LinkedIn

Website: fda.gov Description: The Orphan Drug Designation program provides orphan status to drugs and biologics which are defined as those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the U.S., or that affect more than 200,000 persons but are not expected to recover the costs of developing and marketing a treatment drug.

  • Feed

© 2012-2016 karmadata, Inc. All rights reserved.

Connect with karmadata

Flipboard Pinterest Facebook Twitter LinkedIn